- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00002065
Depot Disulfiram for AIDS and ARC
June 23, 2005 updated by: St. Vincent's Medical Center
To assess the safety and efficacy of depot disulfiram as a new treatment for AIDS and AIDS related complex.
Study Overview
Study Type
Interventional
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
Staten Island, New York, United States, 10310
- Saint Vincent's Med Ctr
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria
Patients must have a positive diagnosis of AIDS or AIDS related complex (ARC) according to the CDC criteria.
- Also patient must be:
- Able to understand the study.
- Strongly motivated to participate in the study, and willing to comply with all the conditions specified in the informed consent forms.
- Ambulatory and able to maintain an independent life outside the hospital.
- Free of clinically significant organic disease affecting neurologic, hepatic, renal, and clinical status.
Patients must be free of clinically significant organic disease affecting neurologic, hepatic, renal, and clinical status.
Patients must be free of clinically significant organic disease affecting neurologic, hepatic, renal, and clinical status.
History of alcohol abuse.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Masking: None (Open Label)
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Registration Dates
First Submitted
November 2, 1999
First Submitted That Met QC Criteria
August 30, 2001
First Posted (Estimate)
August 31, 2001
Study Record Updates
Last Update Posted (Estimate)
June 24, 2005
Last Update Submitted That Met QC Criteria
June 23, 2005
Last Verified
November 1, 1999
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- RNA Virus Infections
- Virus Diseases
- Infections
- Blood-Borne Infections
- Communicable Diseases
- Sexually Transmitted Diseases, Viral
- Sexually Transmitted Diseases
- Lentivirus Infections
- Retroviridae Infections
- Immunologic Deficiency Syndromes
- Immune System Diseases
- HIV Infections
- Molecular Mechanisms of Pharmacological Action
- Enzyme Inhibitors
- Alcohol Deterrents
- Acetaldehyde Dehydrogenase Inhibitors
- Disulfiram
Other Study ID Numbers
- 024A
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.